223 related articles for article (PubMed ID: 12672960)
21. Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
Kelly GL; Stylianou J; Rasaiyaah J; Wei W; Thomas W; Croom-Carter D; Kohler C; Spang R; Woodman C; Kellam P; Rickinson AB; Bell AI
J Virol; 2013 Mar; 87(5):2882-94. PubMed ID: 23269792
[TBL] [Abstract][Full Text] [Related]
22. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
24. The AT-rich region between -54 to -66 is important for the promoter activity of interleukin-10 in Epstein-Barr virus positive Burkitt's lymphoma cells.
Kube D; Laser H; von Knethen A; Tesch H
Genes Immun; 1999 Nov; 1(2):105-14. PubMed ID: 11196656
[TBL] [Abstract][Full Text] [Related]
25. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion.
Thielen C; Herens C; Fassotte MF; Detrooz E; Drion P; Diss T; Boniver J; de Leval L
Eur J Haematol; 2006 Oct; 77(4):318-26. PubMed ID: 16856916
[TBL] [Abstract][Full Text] [Related]
26. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
Nagy E; Veress G; Szarka K; Csoma E; Beck Z
Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
[TBL] [Abstract][Full Text] [Related]
27. [Localization of 8q24 break-point of Burkitt lymphoma in Japan : relationship to EBV status].
Tatsumi E; Ohno H
Nihon Rinsho; 1997 Feb; 55(2):429-35. PubMed ID: 9046836
[TBL] [Abstract][Full Text] [Related]
28. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.
Boccellato F; Anastasiadou E; Rosato P; Kempkes B; Frati L; Faggioni A; Trivedi P
J Virol; 2007 Mar; 81(5):2274-82. PubMed ID: 17151114
[TBL] [Abstract][Full Text] [Related]
29. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
30. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation.
Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E
Int J Cancer; 2002 Aug; 100(4):433-40. PubMed ID: 12115526
[TBL] [Abstract][Full Text] [Related]
31. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
32. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
33. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
34. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Stewart JP; Behm FG; Arrand JR; Rooney CM
Virology; 1994 May; 200(2):724-32. PubMed ID: 8178456
[TBL] [Abstract][Full Text] [Related]
36. Involvement of 5-lipoxygenase in survival of Epstein-Barr virus (EBV)-converted B lymphoma cells.
Belfiore MC; Natoni A; Barzellotti R; Merendino N; Pessina G; Ghibelli L; Gualandi G
Cancer Lett; 2007 Sep; 254(2):236-43. PubMed ID: 17467166
[TBL] [Abstract][Full Text] [Related]
37. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
38. Cooperation between cellular and Epstein-Barr virus genes in the genesis of Burkitt's lymphoma.
Calender A; Billaud M; Lenoir G
IARC Sci Publ; 1988; (92):159-64. PubMed ID: 2853138
[No Abstract] [Full Text] [Related]
39. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
[TBL] [Abstract][Full Text] [Related]
40. Changes in the protein composition of Epstein-Barr Virus-negative lymphoma cells after EBV-conversion.
Siegert W; Mönch T
Anticancer Res; 1983; 3(1):11-6. PubMed ID: 6299173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
